Stock Analysis on Net
Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)

This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

Allergan Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011 Dec 31, 2010 Sep 30, 2010 Jun 30, 2010 Mar 31, 2010
Notes payable 0.58 0.48 0.55 0.57 0.53 0.37 0.53 0.62 0.53 0.46 0.49 1.01 0.99 0.96 0.97 0.43 0.34 0.22 0.17 0.23
Convertible notes 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.75 7.73 7.45 8.09 0.00
Accounts payable 2.31 2.43 2.73 2.95 2.68 2.64 2.45 2.36 2.54 2.36 2.31 2.34 2.36 2.32 2.54 2.40 2.68 2.42 2.55 3.38
Accrued compensation 2.36 2.30 1.93 1.57 2.54 2.38 2.02 1.69 2.44 2.30 1.87 1.49 2.36 2.28 2.17 1.42 2.20 1.98 1.90 1.29
Accrued legal settlement expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.14 0.00 0.00
Other accrued expenses 7.29 8.24 7.59 6.55 5.65 6.24 6.31 6.75 6.42 6.69 6.44 6.32 5.52 5.72 6.02 5.63 5.26 5.06 4.97 5.09
Income taxes 0.00 0.00 0.00 0.00 0.37 0.17 0.00 0.00 0.00 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.19 0.25 0.55 0.27
Liabilities of discontinued operations 0.00 0.00 0.00 0.00 0.00 0.03 0.04 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current liabilities 12.54% 13.46% 12.80% 11.64% 11.77% 11.83% 11.35% 11.48% 11.93% 11.84% 11.11% 11.16% 11.22% 11.29% 11.69% 17.63% 18.40% 24.51% 18.23% 10.27%
Long-term debt, excluding current maturities 16.80 17.93 19.03 19.54 19.84 20.72 21.75 22.78 16.48 17.01 17.47 17.44 17.81 18.53 19.17 18.27 18.47 18.10 11.41 11.51
Long-term convertible notes 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.17
Other liabilities 8.14 7.48 6.35 7.01 7.21 7.20 7.50 7.77 7.72 8.37 8.45 8.29 8.30 7.52 5.83 5.70 5.59 4.88 4.74 4.94
Non-current liabilities 24.93% 25.42% 25.39% 26.56% 27.05% 27.91% 29.25% 30.56% 24.20% 25.38% 25.92% 25.73% 26.11% 26.05% 24.99% 23.98% 24.06% 22.98% 16.15% 24.62%
Total liabilities 37.47% 38.87% 38.18% 38.20% 38.82% 39.74% 40.60% 42.03% 36.13% 37.22% 37.03% 36.89% 37.33% 37.34% 36.69% 41.60% 42.45% 47.49% 34.39% 34.89%
Preferred stock, $.01 par value; none issued 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, $.01 par value 0.02 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.03 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04
Additional paid-in capital 27.01 27.90 29.06 29.15 28.68 29.62 30.76 31.90 31.60 32.03 32.56 32.17 32.46 33.30 34.30 33.79 33.89 32.49 35.33 35.87
Accumulated other comprehensive loss -3.29 -2.52 -1.97 -2.09 -2.14 -2.49 -2.92 -2.87 -2.66 -2.75 -2.98 -2.52 -2.84 -2.19 -1.27 -1.57 -1.84 -1.23 -2.14 -1.61
Retained earnings 47.48 46.47 46.76 44.69 43.94 43.01 42.27 40.67 41.75 40.43 39.06 36.10 34.90 33.63 32.11 27.98 26.79 23.77 34.97 32.76
Treasury stock, at cost -8.78 -10.82 -12.13 -10.04 -9.39 -10.19 -11.00 -12.03 -7.13 -7.25 -5.97 -2.94 -2.15 -2.40 -2.18 -2.11 -1.61 -2.85 -2.87 -2.23
Total Allergan, Inc. stockholders’ equity 62.45% 61.06% 61.74% 61.73% 61.12% 59.99% 59.14% 57.70% 63.59% 62.50% 62.71% 62.86% 62.40% 62.39% 63.00% 58.13% 57.27% 52.22% 65.33% 64.82%
Noncontrolling interest 0.08 0.07 0.08 0.07 0.06 0.27 0.26 0.27 0.28 0.28 0.26 0.26 0.27 0.28 0.31 0.27 0.28 0.29 0.28 0.29
Total equity 62.53% 61.13% 61.82% 61.80% 61.18% 60.26% 59.40% 57.97% 63.87% 62.78% 62.97% 63.11% 62.67% 62.66% 63.31% 58.40% 57.55% 52.51% 65.61% 65.11%
Total liabilities and equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31), 10-K (reporting date: 2010-12-31), 10-Q (reporting date: 2010-09-30), 10-Q (reporting date: 2010-06-30), 10-Q (reporting date: 2010-03-31).

Liabilities Overview
The total liabilities as a percentage of total liabilities and equity fluctuate between approximately 34% and 47%, indicating some volatility over the observed periods. Notably, there is a peak in liabilities in late 2010 and early 2013, followed by a moderate decline towards late 2014.
Current Liabilities
Current liabilities show irregular movements, with a significant peak at 24.51% in September 2010 and lower levels around 11-13% in the subsequent years. The data implies episodes of increased short-term obligations in early periods, with relatively stabilized but slightly increasing levels near the end of the timeline.
Long-Term Debt
Long-term debt, excluding current maturities, remains a substantial component, ranging roughly from 11.4% in early 2010 to a high of nearly 23% around the first quarter of 2013, then trending downward to approximately 16.8% by the end of 2014. This indicates debt restructuring or repayments during later periods.
Convertible Notes
Convertible notes are recorded primarily in mid to late 2010 and early 2011, comprising around 7-8% of total liabilities and equity, after which their presence declines to zero, suggesting the conversion or retirement of these instruments.
Accrued and Other Liabilities
Other accrued expenses exhibit a gradual increase from just above 5% to a peak exceeding 8% by late 2014, implying rising short-term obligations or accruals. Accrued compensation fluctuates between 1.3% and 2.6%, showing moderate variation likely linked to payroll and employee-related liabilities. 'Other liabilities' grow from around 5% to above 8% near the end of the period, indicating an increasing share of miscellaneous obligations.
Equity Composition
Total equity consistently accounts for about 57% to 65% of total liabilities and equity, with a dip in 2010-2011 and a gradual recovery from 2012 onwards. Additional paid-in capital declines steadily from nearly 36% in early 2010 to about 27% by the end of 2014, suggestive of reduced capital contributions or accounting adjustments.
Retained Earnings and Treasury Stock
Retained earnings display an overall upward trend, increasing steadily from approximately 33% to close to 47%, indicating accumulated profits over time. Conversely, treasury stock at cost shows a sizeable increase in negative value, particularly from 2012 onward, reaching as low as -12% near 2013 and around -8.8% in late 2014. This suggests substantial stock repurchases or retirements.
Comprehensive Loss and Other Equity Items
Accumulated other comprehensive loss remains negative throughout the periods, with increasing magnitude toward the end, reaching about -3.3%. This points to unfavorable adjustments in items such as foreign currency translation or pension liabilities. Common stock remains negligible and stable, while noncontrolling interest maintains a minimal portion around 0.07% to 0.31%.
Summary of Trends
The company’s financial structure reveals a shift from higher reliance on current liabilities and convertible notes in 2010-2011 towards a somewhat greater emphasis on long-term debt in subsequent years, albeit with gradual deleveraging from 2013 to 2014. Stockholders’ equity strengthens over time, supported primarily by rising retained earnings, despite decreasing additional paid-in capital and increasing treasury stock activity. The upward trajectory in accrued and other liabilities highlights a growing portion of operational or contingent obligations. Overall, the balance between liabilities and equity appears relatively stable with moderate fluctuations in specific categories reflecting changing financing and operational dynamics.

AI Ask an analyst for more